Reperfusion After Fibrinolytic Therapy

The safety and efficacy profile of bivalirudin has not been examined in a randomised controlled trial of patients undergoing rescue PCI. We conducted an open-label, multi-centre, randomised controlled trial to compare bivalirudin with heparin ± glycoprotein IIb/IIIa inhibitors (GPIs) in patients und...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	PloS one 2021-10, Vol.16 (10), p.e0259148
Hauptverfasser:	Faour, Amir, Collins, Nicholas, Williams, Trent, Khan, Arshad, Juergens, Craig P, Lo, Sidney, Walters, Darren L, Chew, Derek P, French, John K
Format:	Artikel
Sprache:	eng
Schlagworte:	Bivalirudin Cardiac patients Care and treatment Comparative analysis Complications and side effects Coronary heart disease Diagnosis Dosage and administration Hemorrhage Heparin Minimally invasive surgery Patient outcomes Reperfusion injury Risk factors Thrombolytic drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!